Interactions Between Environmental Exposures and Gut Microbiota in Early Life

NCT06479928 · tracked via the Priya Life Science China tracker

Sponsor

Peking University People's Hospital

Phase

Observational

Started

2023-07-01

Last updated

2024-07-23

Condition(s) studied

Infant Development

Investigational drug(s) / intervention(s)

delivery mode

delivery mode: Based on delivery mode, we will divide them into two groups, including Cesarean section and Natural delivery.

Study summary

Recruit the mothers and their infants who bron in Peking University People's Hospital from 2023 to 2026, to evaluate the interaction between environmental exposure and gut microbiota.

Eligibility

Sex

ALL

Min age

1 Day

Max age

24 Months

Healthy volunteers

Accepted

Inclusion Criteria: 1. Pregnant woman * aged 20-40 years old * natural conception * single pregnancy * gestational age ≥36 weeks 2. Newborn * normal Apgar score * no serious congenital diseases Exclusion Criteria: \-

Primary outcome measure(s)

Arsenic levels and Gut microbiota — Pregnancy (12, 24, 36 weeks) and infants (born, 1 week, and 1, 3, 6, 12, 24 months)
Arsenic levels in biological samples; gut microbiota and metabolites in stools.

Trial sites (1)

Facility	City	Region	Status
The Peking University People's Hospital	Beijing	China	Recruiting

More Peking University People's Hospital trials in China

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors Recruiting

Research on the Application of Patient Navigation-based Management Model of Patients After LEEP Starting soon

IFN-α in Relapse Prevention. Starting soon

ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer Recruiting

CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06479928 on ClinicalTrials.gov ↗ ← All trials in China